Stanford Cancer Center Stanford Cancer Institute (2) — Stanford, California

Stanford Cancer Center Stanford Cancer Institute (2) is a clinical research site located in Stanford, California, United States 94305.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford Cancer Center Stanford Cancer Institute (2) has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Center Stanford Cancer Institute (2)?

Stanford Cancer Center Stanford Cancer Institute (2) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Center Stanford Cancer Institute (2) conducted?

Stanford Cancer Center Stanford Cancer Institute (2) has 1 clinical trials on record. Their work covers Multiple Myeloma.

Is Stanford Cancer Center Stanford Cancer Institute (2) accredited by Crixeo Health?

Stanford Cancer Center Stanford Cancer Institute (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Cancer Center Stanford Cancer Institute (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.